Lars Thomsen on Leveraging Networks to Commercialize a Biochip | GenomeWeb

At A Glance

  • Lars Thomsen, CEO, Thomsen Bioscience, Norresundby, North Jutland, Denmark.
  • MSc — 1991, electrophysiology, Copenhagen University.
  • PhD — 1995, neurophysiology, Copenhagen University.
  • Postdoc — Internal Disease Research Program, McMaster University, Hamilton, Ontario, Canada.

Lars Thomsen, a 39-year-old Danish PhD, has created a biochip that has applications in biosensing, and is designed to wirelessly link into telecom data networks.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.